News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CancerVax Corporation (CNVX) Drug Fails Late-Stage Skin Cancer Trial


3/24/2006 10:28:59 AM

CARLSBAD, CA -- (MARKET WIRE) -- 03/24/2006 -- CancerVax Corporation (NASDAQ: CNVX) announced that data from its Phase 3 clinical trials of Canvaxin™ in the treatment of patients with advanced-stage melanoma will be presented today at the Society for Surgical Oncology's Annual Meeting in San Diego, California.

Read at Reuters
Read at Market Wired

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES